These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25024005)

  • 1. [Association between biochemical markers and left ventricular dysfunction in the ST-elevation acute myocardial infarction].
    de Abreu M; Mariani J; Guridi C; González-Villa-Monte G; Gastaldello N; Potito M; Reyes G; Antonietti L; Tajer C
    Arch Cardiol Mex; 2014; 84(4):243-9. PubMed ID: 25024005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between three-dimensional and two-dimensional echocardiography and biochemical analysis in patients with ST-segment elevation myocardial infarction percutaneously treated.
    Vieira ML; Oliveira WA; Cury AF; Cordovil A; Rodrigues AC; Naccarato GA; Monaco CG; Costa LP; Romano RB; Calatroia JR; Afonso TR; Tavares GM; Guimarães LA; Lira Filho EB; Perin MA; Fischer CH; Morhy SS
    Einstein (Sao Paulo); 2010 Mar; 8(1):53-61. PubMed ID: 26761753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
    Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
    Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction.
    Ben-Dor I; Haim M; Rechavia E; Murninkas D; Harell D; Porter A; Iakobishvili Z; Battler A; Hasdai D
    Angiology; 2006 Dec-2007 Jan; 57(6):686-93. PubMed ID: 17235108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the time course of ST segment elevation just after reperfusion therapy for acute myocardial infarction].
    Mori F; Uchida T; Byun T; Kasanuki H
    J Cardiol; 2000 Jan; 35(1):1-8. PubMed ID: 10654244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third heart sound revisited: a correlation with N-terminal pro brain natriuretic peptide and echocardiography to detect left ventricular dysfunction.
    Narain VS; Puri A; Gilhotra HS; Sadiq PA; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(1):31-4. PubMed ID: 15852891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling.
    Meng L; Wang J; Ding WH; Han P; Yang Y; Qi LT; Zhang BW
    Postgrad Med J; 2013 Apr; 89(1050):193-6. PubMed ID: 23223776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction.
    Grybauskiene R; Karciauskaite D; Brazdzionyte J; Janenaite J; Bertasiene Z; Grybauskas P
    Medicina (Kaunas); 2007; 43(9):708-15. PubMed ID: 17986844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
    Selim NA; Hmouda HT
    Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
    Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
    Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?
    Schäfer U; Kurz T; Jain D; Hartmann F; Dendorfer A; Tölg R; Raasch W; Dominiak P; Katus H; Richardt G
    Basic Res Cardiol; 2002 Sep; 97(5):399-408. PubMed ID: 12200640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): comparison with acute myocardial infarction.
    Ahmed KA; Madhavan M; Prasad A
    Coron Artery Dis; 2012 Jun; 23(4):259-64. PubMed ID: 22395239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
    Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
    Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.